Table 2. Characteristics of patients with established Crohn’s disease.
Variable (n = 43) | Number (%) |
Extent of CD Small-bowel CD Ileo-colonic CD Ileo-colonic and duodenum CD | 14 (32.6)26 (60.5) 3 (6.9) |
Phenotype of CD Stricturing CD Fistulizing CD | 32 (74.4)11 (25.6) |
5-Aminosalicylate use | 10 (23.3) |
Corticosteroid use | 17 (39.5) |
Azathioprine/6-mercaptopurine use | 12 (27.9) |
Biologics use | 20 (46.5) |
Duration of CD, median (range), y | 8 (1 – 14) |
CD, Crohn’s disease.